← Back to Search

Intraocular Lens

AcrySof Toric IOL for Pseudoaphakia

Phase 4
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-operative, 1 month, 3 month, and 6 month post-operative
Awards & highlights
Pivotal Trial
No Placebo-Only Group
Drug Has Already Been Approved

Summary

The purpose of this study is to evaluate the effect that placement and power of the AcrySof Toric has on post-operative visual acuity and spectacle independence for distance vision. This will be determined by comparing manifest refraction pre-operatively and post-operatively and by evaluating the rotational stability of the lens over time.

Eligible Conditions
  • Pseudoaphakia
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-operative, 1 month, 3 month, and 6 month post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-operative, 1 month, 3 month, and 6 month post-operative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Acuity (VA)
Secondary study objectives
IOL Rotation
Spectacle Independence

Side effects data

From undefined Phase 4 trial • 120 Patients • NCT00760487
1%
Lens Repositioning
100%
80%
60%
40%
20%
0%
Study treatment Arm
AcrySof Toric IOL

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AcrySof Toric IOLExperimental Treatment1 Intervention
AcrySof Toric Intraocular Lens (IOL)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AcrySof Toric IOL
2006
Completed Phase 4
~120

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
730 Previous Clinical Trials
128,731 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top